Voss Capital, LP's Form 4 filing
Rein Therapeutics, Inc. (RNTX) · filed Nov 18, 2025
- Accession no.
- 0000921895-25-003156
- Filed
- Nov 18, 2025, 5:30 PM ET
- Trade date
- Nov 14, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $127.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Voss Capital, LPCIK 0001730145 | 10% Owner |
| Voss Advisors GP, LLCCIK 0001798309 | 10% Owner |
| Cocke Travis W.CIK 0001798383 | 10% Owner |
| Voss Value-Oriented Special Situations Fund, LPCIK 0001863498 | 10% Owner |
| Voss Value Master Fund, LPCIK 0001969435 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Common Stock, $0.001 par value | PPurchaseAcquired | +104,183 | $1.22 | +$127,592.92 | 926,441 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.